Member Info for formerlyeasyp

If were the company who currently have the PSA licence/patent/production then I would want to buy OBD this week for the simple reason that one then has a monopoly on a test for a very common cancer with a 94% accuracy rating. Probably not quite that simple but not far off imo.

Yesterday afternoon I took some profits as I was taken aback by the market reaction. This morning having considered the news I put a fill or kill order in with HL to buy back most of what I sold. I suspect the market will realise in a few minutes time that OBD is still under priced at this level.

RNS today suggests it is less of a gamble than perhaps a year ago?

And suddenly the clouds cleared and he was back in the blue? Good luck all a great day for OBD and its shareholders.

#metoo thought we might clear 20% in the first hour but happy to wait for the news and financial numbers to sink in with the market. LTH imo.

Willing to wait months for folks to wake up to this test. Share price will follow imo.

The OBD product takes a PSA test from 55% accurate to 90+% accurate......

But added to OBD, please excuse this blatant piece of ramping but take a look at their RNS issued this morning:

Oxford BioDynamics Plc

Oxford Biodynamics launches the 94% accurate EpiSwitch® Prostate Screeningblood test (PSE) for men with prostate cancer risk in the US and UK

· Validation completed in OBD's US CLIA-certified clinical laboratory ahead of time - enabling immediate launch of the EpiSwitch Prostate Screening (PSE) test

· PSE is designed to run alongside a standard PSA test

· PSE boosts PSA predictive accuracy from 55% to 94% for determining the presence or absence of prostate cancer

· Increased accuracy of diagnosis significantly reduces false positives, thus decreasing unnecessary referrals for invasive biopsies

Oxford BioDynamics Plc

Oxford Biodynamics launches the 94% accurate EpiSwitch® Prostate Screeningblood test (PSE) for men with prostate cancer risk in the US and UK

· Validation completed in OBD's US CLIA-certified clinical laboratory ahead of time - enabling immediate launch of the EpiSwitch Prostate Screening (PSE) test

· PSE is designed to run alongside a standard PSA test

· PSE boosts PSA predictive accuracy from 55% to 94% for determining the presence or absence of prostate cancer

· Increased accuracy of diagnosis significantly reduces false positives, thus decreasing unnecessary referrals for invasive biopsies

Huge.....simply because the US and UK market is so large. 390 million combined population say 190 million men of whom many are boomers and in the prostate worry zone. OBD has a test which takes the PSA test accuracy from 53% to 93% certain.

Very impressed! Should lift the sp.

We do not own anywhere near enough shares to oust a CEO.

Even a legal challenge against HUR did not result in us getting the CEO fired.

Idly looked at the results as I scan RNS every trading day for anything of interest. Financially looks good, politically very risky place to conduct business but I did wonder what it would be worth in a few years hence with the war over and most sanctions gone? I also wondered how much oil might start flowing into Asia rather than the EU?

Why some of us top slice some profits from a good run up in price.

Not alarmed, fair price and funds the next phase of development. I would like to see some JV money from larger mining companies funding exploration in 2024 and beyond.

Is farce a polite word for fraud?

The language of AIM stocks all rather confusing.

MURF share price volatile!

Hoping for positive news from the USA before Christmas.

Hope it goes well for shareholders but I will buy back in once we have firm news.

Answer....it's China.

Opaque and inscrutable but you are correct, the UK management should be telling us why via an RNS.

The day not over and sometimes RNS are released on a Friday afternoon.

Looks like a good finish to the week.

News of further orders will push the sp higher imo.

My guess is more news within 3 months, DYOR.

Good luck all, recognise the pattern of decline and decided to cut my losses.

Unsurprised to see a fallback in price after such an epic run up but wondering when to add to my stake? 4p or a little under? Good drilling news in the next few months will push the sp back up imo.

Tygra go check out what they were saying about ORCA in mid August. Issue price of 40p, share price sub 10p, CEO paid too much etc. Much the same as we are complaining about here. That said I am realist who purchased recently and am still down 20% so not entirely blind to what a dog this company has become. I still feel a bid is possible but prob for close to 1.5p not 15p.